Welcome to the EAS 2023 Interactive Program
The congress will officially run on CET time zone (Central European Time)
Session Type
Industry Session
Date
Mon, 22.05.2023
Session Time
14:45 - 15:30
Room
Hall: Heinrich Otto Wieland
Session Description
Inclisiran: emerging evidence for strategies to reach LDL-C targets - Industry Sponsored Session by Novartis.
Novartis invites you to join an interesting and informative Medical Special Lecture on LDL-C in ASCVD with our expert faculty. In this session, Professor Landmesser from Germany will take you through the importance and challenges of achieving and maintaining LDL-C goals. Professor Ray from the UK will discuss the key data on the efficacy and safety of inclisiran for LDL-C management in ASCVD. Professor Wright from the USA will present pooled safety data from the ORION clinical trials programme and will discuss the ongoing VICTORION clinical trials programme. The presentations will be followed by a 10-minute Q&A session.
Addressing a global CV disease crisis: therapies for LDL-C management (ID 1552)
Session Type
Industry Session
Date
Mon, 22.05.2023
Session Time
14:45 - 15:30
Room
Hall: Heinrich Otto Wieland
Presenter
Lecture Time
14:45 - 14:55
The role of inclisiran in lipid management: long-term efficacy and safety (ID 1553)
Session Type
Industry Session
Date
Mon, 22.05.2023
Session Time
14:45 - 15:30
Room
Hall: Heinrich Otto Wieland
Presenter
Lecture Time
14:55 - 15:05
Pooled safety and the future of care with inclisiran (ID 1554)
Session Type
Industry Session
Date
Mon, 22.05.2023
Session Time
14:45 - 15:30
Room
Hall: Heinrich Otto Wieland
Lecture Time
15:05 - 15:20
Q&A and session close (ID 1555)
Session Type
Industry Session
Date
Mon, 22.05.2023
Session Time
14:45 - 15:30
Room
Hall: Heinrich Otto Wieland
Presenter
Lecture Time
15:20 - 15:30